Diffuse large b-cell lymphoma stage iii and Atrial fibrillation/flutter

Summary:

Atrial fibrillation/flutter is found among people with Diffuse large b-cell lymphoma stage iii, especially for people who are male, 60+ old.

The study analyzes which people have Atrial fibrillation/flutter with Diffuse large b-cell lymphoma stage iii. It is created by eHealthMe based on reports of 17 people who have Diffuse large b-cell lymphoma stage iii from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Diffuse large b-cell lymphoma stage iii?

Diffuse large b-cell lymphoma stage iii (cancer of b cells, a type of white blood cell-stage iii) is found to be associated with 13 drugs and 69 conditions by eHealthMe. Check the latest studies of Diffuse large b-cell lymphoma stage iii.

What is Atrial fibrillation/flutter?

Atrial fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles) is found to be associated with 2,364 drugs and 3,841 conditions by eHealthMe. Check the latest studies of Atrial fibrillation/flutter.

On Jul, 20, 2026

17 people who have Diffuse Large B-Cell Lymphoma Stage Iii and Atrial Fibrillation/Flutter are studied.

Would you have Atrial fibrillation/flutter when you have Diffuse large b-cell lymphoma stage iii?

Gender of people who have Diffuse Large B-Cell Lymphoma Stage Iii and experienced Atrial Fibrillation/Flutter *:

female: 38.46 %
male: 61.54 %

Age of people who have Diffuse Large B-Cell Lymphoma Stage Iii and experienced Atrial Fibrillation/Flutter *:

Common co-existing conditions for these people *:

Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 7 people, 41.18%
Post Transplant Lymphoproliferative Disorder: 2 people, 11.76%
Tumor Lysis Syndrome: 1 person, 5.88%

Common drugs taken by these people *:

Prednisone: 14 people, 82.35%
Cyclophosphamide: 13 people, 76.47%
Allopurinol: 6 people, 35.29%
Omeprazole: 6 people, 35.29%
Vincristine Sulfate: 5 people, 29.41%
Valacyclovir Hydrochloride: 5 people, 29.41%
Bisoprolol Fumarate: 5 people, 29.41%
Doxorubicin Hydrochloride: 5 people, 29.41%
Euthyrox: 5 people, 29.41%
Fluconazole: 5 people, 29.41%

Common symptoms for these people *:

Febrile Neutropenia (fever with reduced white blood cells): 11 people, 64.71%
Cytokine Release Syndrome (immediate complication occurring with the use of anti-t cell antibody infusions): 6 people, 35.29%
Fever: 5 people, 29.41%
High Blood Pressure: 4 people, 23.53%
Respiratory Tract Infection: 3 people, 17.65%
Weakness: 2 people, 11.76%
Urination - Painful: 2 people, 11.76%
Anaemia (lack of blood): 2 people, 11.76%
Klebsiella Infection: 2 people, 11.76%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 2 people, 11.76%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Atrial fibrillation/flutter?

- Check whether Atrial fibrillation/flutter is associated with a drug or a condition

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Atrial fibrillation/flutter and Diffuse large b-cell lymphoma stage iii, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.